Bookmark Article
Liquid biopsy, a minimally invasive procedure, is gaining popularity for cancer detection through screening for biomarkers like cell-free DNA (cfDNA) using next-generation sequencing (NGS). Twist Bioscience has developed the Twist cfDNA Library Preparation Kit to address challenges in sequencing cfDNA, offering higher yields, better coverage, and more sensitive detection of low-frequency variants. The kit has shown significant improvements in performance, especially for detecting circulating tumor DNA (ctDNA), and has been well-received by clinicians and researchers for its efficiency and accuracy in developing sensitive ctDNA assays for oncology research.
Full Article
